Literature DB >> 11261894

Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs.

M G Jakab1, J Major, A Tompa.   

Abstract

Most of the antineoplastic drugs used in the treatment of tumors are carcinogenic to humans. Hospital nurses are often subject to possible occupational carcinogen exposure. Exposure may occur during handling and administration of infusion solutions containing cytostatics. A genotoxicological monitoring system to detect genotoxic changes was developed in our laboratory, helping to improve working conditions and subserving primary prevention. Multiple-endpoint follow-up genotoxicological monitoring was performed in peripheral blood lymphocytes (PBLs) among 4 groups of 95 nurses (152 investigations) occupationally exposed to cytostatics. The results were compared to those of historical and industrial controls. The genotoxicological endpoints were the determination of the frequency of sister chromatid exchanges (SCEs) and the cells with high-frequency SCEs (HFC), the frequency of structural and numerical chromosome aberrations. and the measurement of ultraviolet-light-induced unscheduled DNA-repair synthesis (UDS). In Hospital 1, where nurses worked without a safety cabinet, the percentage of cells with chromosome aberrations (AC) was significantly higher than that of the controls. In Hospital 2, where nurses used inadequate safety cabinets (with horizontal airflow), significantly elevated levels of AC, SCE, HFC, and UDS were detected. During follow-up, in Hospital 2 at the time of the second investigation AC was still significantly higher, although safety conditions had been improved. The results indicate the presence of genotoxic damage in hospital nurses working with no or inadequate safety equipment. In Hospitals 3 and 4 where nurses using biological safety cabinets, the results were lower than those in the previous two groups. In Hospital 3 in the first year of the study AC was as at the level of industrial controls. During follow-up in the course of the repeated investigations a fluctuation in AC above the control level and an increase in HFC in yr 4 and 6 of the study were observed. In this group, the fluctuation in AC and HFC during the study points to the possibility of genotoxic exposure with cytostatics despite of the use of suitable safety cabinets, drawing attention to other possible routes of exposure. In Hospital 4, both AC and HFC were elevated. These data corroborate the need to maintain safety measures to avoid exposure, and the necessity of intervention in the case of exposure when using and handling hazardous carcinogenic agents. The results also indicate a certain expression time for genotoxic changes, which can lead to late somatic mutations as well as to a possible higher risk of cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11261894     DOI: 10.1080/152873901300018011

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  8 in total

1.  Factors Influencing Nurses' Use of Hazardous Drug Safe-Handling Precautions.

Authors:  Amy Callahan; Nancy J Ames; Mary Lou Manning; Kate Touchton-Leonard; Li Yang; Gwenyth Wallen
Journal:  Oncol Nurs Forum       Date:  2016-05-01       Impact factor: 2.172

2.  Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach.

Authors:  Massimo Moretti; Maria Giuseppa Grollino; Sofia Pavanello; Roberta Bonfiglioli; Milena Villarini; Massimo Appolloni; Mariella Carrieri; Laura Sabatini; Luca Dominici; Laura Stronati; Giuseppe Mastrangelo; Anna Barbieri; Cristina Fatigoni; Giovanni Battista Bartolucci; Elisabetta Ceretti; Francesca Mussi; Silvano Monarca
Journal:  Int Arch Occup Environ Health       Date:  2014-11-02       Impact factor: 3.015

3.  Immunotoxicity monitoring of hospital staff occupationally exposed to cytostatic drugs.

Authors:  Anna Biró; Zoltán Fodor; Jeno Major; Anna Tompa
Journal:  Pathol Oncol Res       Date:  2010-11-27       Impact factor: 3.201

4.  A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.

Authors:  Massimo Moretti; Roberta Bonfiglioli; Donatella Feretti; Sofia Pavanello; Francesca Mussi; Maria G Grollino; Milena Villarini; Anna Barbieri; Elisabetta Ceretti; Mariella Carrieri; Annamaria Buschini; Massimo Appolloni; Luca Dominici; Laura Sabatini; Umberto Gelatti; Giovanni B Bartolucci; Paola Poli; Laura Stronati; Giuseppe Mastrangelo; Silvano Monarca
Journal:  BMC Public Health       Date:  2011-03-30       Impact factor: 3.295

5.  Genotoxic Monitoring of Nurses Handling Cytotoxic Drugs.

Authors:  Anna Tompa; Anna Biró; Mátyás Jakab
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Oct-Dec

6.  A Predictive Model Assessing Genetic Susceptibility Risk at Workplace.

Authors:  Pieranna Chiarella; Pasquale Capone; Damiano Carbonari; Renata Sisto
Journal:  Int J Environ Res Public Health       Date:  2019-06-05       Impact factor: 3.390

Review 7.  DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

Authors:  Ida Casorelli; Cecilia Bossa; Margherita Bignami
Journal:  Int J Environ Res Public Health       Date:  2012-07-27       Impact factor: 3.390

8.  ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice.

Authors:  Annette N Smith; Shawna Klahn; Brenda Phillips; Lisa Parshley; Peter Bennett; Andi Flory; Rosemary Calderon
Journal:  J Vet Intern Med       Date:  2018-03-30       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.